chromium has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, CH; Chang, GR; Hou, PH; Liao, HJ; Lin, CF; Lin, JW; Lin, TC; Lin, WL; Liu, HY; Wang, CM; Wang, YC; Wu, CF; Yang, WC | 1 |
1 other study(ies) available for chromium and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice.
Topics: Adipocytes; Animals; Biomarkers; Body Weights and Measures; Chromium; Clozapine; Disease Models, Animal; Fatty Acid-Binding Proteins; Fluorescent Antibody Technique; Gene Expression; Gene Expression Regulation; Glucose Intolerance; Immunohistochemistry; Insulin; Kidney Diseases; Liver; Mice; Mice, Obese; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Obesity; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Retinal Diseases; Sterol Regulatory Element Binding Protein 1 | 2021 |